ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,842Medicare Part D Prescriptions Filled, Including Refills

Rank: 390 out of 1499

$404K Total Retail Price of All Prescriptions

Rank: 480 out of 1499

456 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 5,350 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LISINOPRIL 437 265 1 1
LEVOTHYROXINE SODIUM 329 214 2 2
OMEPRAZOLE 300 134 3 5
HYDROCODONE-ACETAMINOPHEN 288 207 S3 4 4
METFORMIN HCL 284 158 5 8
SIMVASTATIN 224 147 6 3
ATORVASTATIN CALCIUM 205 156 7 17
AMLODIPINE BESYLATE 185 145 8 6
GABAPENTIN 183 113 9 13
FUROSEMIDE 178 115 10 7
CITALOPRAM HBR 150 82 11 14
LEVOFLOXACIN 138 90 12 101
LOSARTAN POTASSIUM 134 111 13 26
METOPROLOL TARTRATE 130 87 14 10
HYDROCHLOROTHIAZIDE 118 69 15 9
ATENOLOL 115 87 16 21
PROAIR HFA 115 83 16 30
POTASSIUM CHLORIDE 114 62 18 11
GLIPIZIDE 112 55 19 64
MELOXICAM 106 75 20 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 75 21 25
CYMBALTA 99 52 22 40
RANITIDINE HCL 97 52 23 15
CARVEDILOL 96 62 24 22
TRAMADOL HCL 95 43 25 16
TRAZODONE HCL 89 40 26 32
WARFARIN SODIUM 87 59 27 12
AZITHROMYCIN 85 66 28 45
LANTUS 85 59 28 46
PRAVASTATIN SODIUM 82 53 30 18
NEXIUM 81 35 31 28
SERTRALINE HCL 79 26 32 24
SYMBICORT 75 54 33 121
CIPROFLOXACIN HCL 72 59 34 65
CELEBREX 68 44 35 77
ALLOPURINOL 67 67 36 36
LOVASTATIN 65 39 37 19
FLUOXETINE HCL 65 19 37 43
CEPHALEXIN 63 55 39 83
METOPROLOL SUCCINATE 62 53 40 20
FLUTICASONE PROPIONATE 58 38 41 31
COMBIVENT 56 13 42 78
PRENATAL PLUS 53 20 43 157
ACTOS 52 45 44 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.